Altamira Therapeutics Ltd (NASDAQ: CYTO) is -86.67% lower on its value in year-to-date trading and has touched a low of $0.40 and a high of $12.80 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CYTO stock was last observed hovering at around $0.48 in the last trading session, with the day’s loss setting it -0.02%.
Currently trading at $0.46, the stock is 3.91% and -12.23% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.81 million and changing -3.09% at the moment leaves the stock -60.66% off its SMA200. CYTO registered -92.38% loss for a year compared to 6-month loss of -68.86%. The firm has a 50-day simple moving average (SMA 50) of $0.53334 and a 200-day simple moving average (SMA200) of $1.186655.
The stock witnessed a -10.42% gain in the last 1 month and extending the period to 3 months gives it a -49.57%, and is 10.08% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.81% over the week and 12.99% over the month.
Distance from 52-week low is 16.00% and -96.38% from its 52-week high.
The EPS is expected to grow by 84.03% this year
The shares outstanding are 3.78M, and float is at 3.76M with Short Float at 2.80%.
